市場調查報告書
商品編碼
1466596
近紅外線成像市場:按產品、應用和最終用戶分類 - 2024-2030 年全球預測Near Infrared Imaging Market by Product (Devices, Dyes, Reagents), Application (Cancer Surgeries, Cardiovascular Surgeries, Gastrointestinal Surgeries), End User - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年近紅外線成像市場規模為25.2億美元,預計2024年將達26.5億美元,2030年將達36億美元,複合年成長率為5.22%。
近紅外線成像 (NIRI) 是一種非侵入性診斷技術,使用大約 700 至 2,500 奈米的近紅外線光波長來拍攝活組織影像。近紅外線光可以深入組織並提供有關底層結構和生化成分的有價值的資訊。檢測器技術的進步和更複雜的影像分析演算法的開發正在提高醫療保健領域的影像品質。需要非侵入性診斷的外科手術數量不斷增加,增加了對近紅外線影像的需求。然而,NIRI 的技術限制可能會阻礙其在全球醫療應用中的實用性。正在進行的研究重點是更靈敏檢測器的創新、影像處理演算法的增強,以及將 NIRI 與 MRI 和 CT 等其他顯像模式相結合,以提高穿透深度和資料準確性。隨著個人化醫療趨勢的不斷發展,診斷和病患監測的應用有望擴大,生物識別安全的新應用也不斷湧現。將 NIRI 與穿戴式裝置等其他技術整合,可實現健康參數的持續即時監測。
主要市場統計 | |
---|---|
基準年[2023] | 25.2億美元 |
預測年份 [2024] | 26.5億美元 |
預測年份 [2030] | 36億美元 |
複合年成長率(%) | 5.22% |
介紹即時提供高解析度影像的先進近紅外線成像系統
近紅外線(NIR)設備包括醫療領域用於影像處理的各種設備,例如攝影機、視訊系統和其他視覺化平台。這些設備在手術過程中即時提供重要訊息,包括血流、組織灌注和氧合的可視化。近紅外線光學相干斷層掃描 (NIR-OCT) 是一種非侵入性成像技術使用近紅外線光從光散射介質內捕捉微米解析度的3D影像。該技術廣泛應用於臨床和生物醫學研究,例如眼科(對於視網膜疾病的診斷至關重要)和循環系統(用於評估血管病變)。近紅外線(NIR) 光譜儀是一種測量近紅外線光吸收、透射和反射的分析設備。它可用於多種行業,包括定量藥物的活性成分、評估作物的健康狀況和水分含量以及用於化學成分分析的材料科學。近紅外光譜儀因其快速分析能力、無損性質以及幾乎不需要樣品製備的探測能力而被使用。 NIR 成像中使用的染料是暴露於近紅外線光時螢光的化合物。這些染料通常與近紅外線設備結合使用,以在醫學成像過程中突出顯示特定的組織和結構。 NIR 試劑包括多種與生物組織發生反應以在 NIR 成像中提供對比的化合物。這些試劑包括探針、生物標記物和其他與特定細胞或蛋白質結合併在近紅外光下可視化的分子。臨床醫生選擇具有高特異性和低背景噪音的試劑來隔離診斷或術中操作中的興趣區域。
應用 近紅外線影像在癌症手術中的快速普及,可準確識別癌症組織
癌症手術中的近紅外線(NIR) 影像是用於識別和區分癌組織和健康組織的重要應用。這使得外科醫生能夠可視化血流、淋巴系統和關鍵的解剖標誌,使他們能夠精確地切除腫瘤,同時保留健康組織。在心血管手術中,近紅外線影像用於評估心肌灌注、評估旁路移植物的通暢性並描繪心臟解剖結構。該應用程式透過提供有關血流和組織灌注的即時資訊,對於確保冠狀動脈繞道手術手術 (CABG) 等手術的成功至關重要。胃腸道手術中的近紅外線影像可以幫助評估腸道灌注、繪製淋巴結圖並進行微創手術。這項技術對於切除術和切除術等手術至關重要,其中組織活力的準確評估至關重要。整形和重組手術中的近紅外線成像主要用於評估組織灌注以確保活力,特別是在皮瓣和移植物的情況下。此應用對於預防乳房切除術後重組和複雜傷口處理中的皮瓣壞死等併發症至關重要。使用近紅外線技術的臨床前造影是一個不斷擴展的領域,主要用於新藥和治療方法的研究和開發。小動物細胞和分子過程的非侵入性視覺化有助於了解疾病機制和治療性介入的有效性。近紅外線成像在藥物發現研發、癌症研究和轉化醫學中特別有價值,並且經常被選擇,因為它可以提供即時資料,並且可以減少動物實驗中侵入性操作的需要。
最終使用者:近紅外線技術在醫院和診斷中心的使用支持臨床決策並提高病人的護理標準。
在醫院和診所,近紅外線成像 (NIRI) 技術主要用於診斷和治療過程,例如血管造影術、整形手術和術中成像以輔助手術。微創手術的進步也推動了醫院和診所對 NIRI 的需求,這需要精確的影像技術。對於製藥和生物技術公司來說,近紅外線成像是藥物發現和開發的工具。它對於研究臨床前和臨床試驗中的生物過程特別有用,可以即時監測藥物分佈和代謝。我們的實驗室將近紅外線成像用於各種應用,包括生物學、化學和材料科學的基礎研究。此外,近紅外線成像由於其非侵入性和提供的詳細資訊而在診斷中心越來越受歡迎。以下是近紅外線成像在這些設施中的主要用途。該領域的偏好取決於成像系統的多功能性、靈敏度和解析度,因為研究人員需要能夠適應不同實驗條件並提供分子和細胞水平的詳細資訊的工具。
區域洞察
美洲,尤其是北美,由於先進的醫療基礎設施、研發 (R&D) 的大量投資以及鼓勵採用創新技術的嚴格監管準則,採用率很高。該地區的主要企業已結成策略聯盟,並保持強大的生產能力,以服務醫療保健產業。由於經濟不斷發展,亞太地區正在經歷快速成長,特別是在中國和印度等新興國家。生產通常受到成本效益和醫療診斷中近紅外線成像日益成長的需求的推動。亞太地區的公司正致力於擴大產品系列併加強銷售網路。歐洲、中東和非洲地區在德國和英國等國家擁有強大的影響力,平衡了歐洲的成熟市場與中東和非洲的新興市場。在歐洲,政府支持措施強調品質以及將近紅外線成像引入科學研究。在外國投資和醫學發現合作夥伴關係的推動下,中東和非洲市場正在逐步採用這些技術。歐洲、中東和非洲地區的公司正在對自己進行策略性定位,以利用歐洲的技術導向和新興市場的成長機會,為多元化的基本客群提供服務。
FPNV定位矩陣
FPNV定位矩陣對於評估近紅外線成像市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對近紅外線成像市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1. 近紅外線成像市場的市場規模和預測是多少?
2.近紅外線成像市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些?
3.近紅外線成像市場的技術趨勢和法規結構是什麼?
4.近紅外線成像市場主要廠商的市場佔有率為何?
5.進入近紅外線成像市場合適的型態和策略手段是什麼?
[185 Pages Report] The Near Infrared Imaging Market size was estimated at USD 2.52 billion in 2023 and expected to reach USD 2.65 billion in 2024, at a CAGR 5.22% to reach USD 3.60 billion by 2030.
Near infrared imaging (NIRI) is a non-invasive diagnostic technology that utilizes near infrared light wavelengths from about 700 to 2500 nanometers, to capture images of biological tissues. NIR light can penetrate deeper into tissues, providing valuable information about the underlying structures and biochemical constituents. Advancements in detector technologies and the development of more advanced algorithms for image analysis are enhancing image quality in healthcare. The increasing number of surgical procedures requiring non-invasive diagnostics creates the need for NIR imaging. However, the technical limitations of NIRI can impede their utility across medical applications worldwide. Ongoing research is focused on the innovation of more sensitive detectors, enhanced algorithms for image processing, and the combination of NIRI with other imaging modalities, such as MRI or CT, to increase penetration depth and data accuracy. The rising trend in personalized medicine is expected to increase its applications in diagnostics and patient monitoring, and new applications in biometric security are emerging. The integration of NIRI with other technologies, such as wearable devices, promises continuous, real-time monitoring of health parameters.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.52 billion |
Estimated Year [2024] | USD 2.65 billion |
Forecast Year [2030] | USD 3.60 billion |
CAGR (%) | 5.22% |
Product: Introduction of advanced NIR imaging systems that provide real-time, high-resolution images
Near infrared (NIR) devices include a variety of instruments used for imaging in the medical field, such as cameras, video systems, and other visualization platforms. These devices provide real-time information that can be crucial during surgical procedures, such as blood flow visualization, tissue perfusion, and oxygenation. Near infrared optical coherence tomography (NIR-OCT) is a non-invasive imaging technique that uses near infrared light to capture micrometer-resolution and three-dimensional images from within optical scattering media. This technology is widely used in clinical and biomedical research for applications such as ophthalmology, which is essential for diagnosing retinal diseases, and cardiology, which is used for assessing vascular pathologies. Near infrared (NIR) spectrometers are analytical instruments that measure a sample's absorption, transmission, and reflectance of NIR light. They are employed in various industries, such as pharmaceuticals for quantifying active pharmaceutical ingredients, agriculture for assessing crop health and moisture content, and materials science for chemical composition analysis. NIR spectrometers are used for their rapid analysis capabilities, non-destructive nature, and ability to probe samples with little to no preparation. Dyes used in NIR imaging are compounds that fluoresce when exposed to near infrared light. These dyes are often used in conjunction with NIR devices to highlight specific tissues or structures during medical imaging. NIR reagents include various compounds that react with biological tissues to provide contrast in NIR imaging. These reagents can include probes, biomarkers, or other molecules that bind to specific cells or proteins, making them visible under NIR light. Clinicians opt for reagents offering high specificity and low background noise to isolate the areas of interest in diagnostic or intraoperative procedures.
Application: Exponential adoption of NIR imaging in cancer surgeries for accurate discrimination of cancerous tissues
Near infrared (NIR) imaging in cancer surgeries is a critical application where it is used to identify and delineate cancerous tissues from healthy tissues. It enables surgeons to visualize the blood flow, lymphatic systems, and key anatomical landmarks, thus assisting in precise tumor removal while sparing healthy tissue. In cardiovascular surgeries, NIR imaging is used to evaluate myocardial perfusion, assess bypass graft patency, and delineate cardiac anatomy. This application is essential to ensure the success of procedures, such as coronary artery bypass grafting (CABG), by providing real-time information on blood flow and tissue perfusion. NIR imaging in gastrointestinal surgeries assists in evaluating bowel perfusion, mapping lymph nodes, and conducting minimally invasive procedures. The technology is indispensable in surgeries such as colectomies and gastrectomies, where an accurate assessment of tissue viability is paramount. NIR imaging in plastic and reconstructive surgeries is primarily used for assessing tissue perfusion to ensure viability, particularly in the case of skin flaps and grafts. This application is crucial to prevent complications such as flap necrosis in breast reconstruction post-mastectomy or in complex wound management. Preclinical imaging utilizing NIR technology is an expanding field primarily used in research and developing new drugs and therapies. It allows non-invasive visualization of cellular and molecular processes in small animals, contributing to understanding disease mechanisms and the effects of therapeutic interventions. NIR imaging is particularly valuable in drug discovery and development, cancer research, and translational medicine, often chosen for its ability to provide real-time data and to reduce the need for invasive procedures in animal studies.
End User: Use of NIR technologies in hospitals and diagnostic centers to support clinical decision-making and improve patient care standards
In hospitals and clinics, near infrared imaging (NIRI) technology is primarily utilized for diagnostic and therapeutic procedures, such as angiography, plastic surgery, and intraoperative imaging to assist in surgeries. The need for NIRI in hospitals and clinics is also driven by the push for minimally invasive surgeries, which require precise imaging technologies. For pharmaceutical and biotechnology companies, near infrared imaging is a tool for drug discovery and development. It is particularly useful for studying biological processes in preclinical and clinical trials, allowing for real-time monitoring of drug distribution and metabolism. Research laboratories use near infrared imaging for a variety of applications, such as basic research in biology, chemistry, and materials science. Moreover, in diagnostic centers, NIR imaging is gaining popularity due to its non-invasive nature and the detailed information it can provide. Below are some of the key applications of NIR imaging in these facilities. The preference in this segment hinges on the versatility, sensitivity, and resolution of the imaging system, as researchers require tools that can adapt to diverse experimental conditions and provide detailed information on the molecular and cellular levels.
Regional Insights
In the Americas, specifically North America, there is a high adoption rate due to advanced healthcare infrastructure, significant investments in research and development (R&D), and stringent regulatory guidelines that promote the adoption of innovative technologies. Major companies in this region engage in strategic collaborations and maintain a robust production landscape to cater to the healthcare sector. The APAC region is witnessing rapid growth due to rising economic development, particularly in emerging countries, including China and India. Production is often driven by cost-effectiveness and increasing demand for near infrared imaging in medical diagnostics. Companies in APAC are focusing on expanding their product portfolio and enhancing distribution networks. The EMEA region, with a strong presence in countries such as Germany and the UK, balances mature markets in Europe with emerging ones in the Middle East and Africa. In Europe, there is a strong emphasis on quality and the integration of NIR imaging in scientific research, backed by supportive government initiatives. The Middle East and African markets are gradually adopting these technologies, often facilitated by foreign investments and partnerships for medical discoveries. Companies in EMEA are strategically positioning themselves to serve a diverse client base, taking advantage of Europe's technology orientation and the developing markets' growth opportunities.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Near Infrared Imaging Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Near Infrared Imaging Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Near Infrared Imaging Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Artinis Medical Systems, Astellas Pharma Inc., BIOPAC Systems, Inc., Biotium, Inc., Bruker Corporation, Carl Zeiss AG, Crysta-Lyn Chemical Company, DIC Corporation, Emberion Oy, Getinge AB, Hamamatsu Photonics K.K., KARL STORZ SE & Co. KG, Leica Microsystems GmbH by Danaher Corporation, LI-COR Biotech LLC, Malvern Panalytical Ltd. by Spectris PLC, Medtronic PLC, Metrohm AG, MIZUHO Corporation, Nikon Corporation, Olympus Corporation, OptoMedic Technologies, Inc., PerkinElmer Inc., SCHOLLY FIBEROPTIC GMBH, Shimadzu Corporation, Soterix Medical Inc., SpectraWAVE, Inc., Stryker Corporation, and Thermo Fisher Scientific Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Near Infrared Imaging Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Near Infrared Imaging Market?
3. What are the technology trends and regulatory frameworks in the Near Infrared Imaging Market?
4. What is the market share of the leading vendors in the Near Infrared Imaging Market?
5. Which modes and strategic moves are suitable for entering the Near Infrared Imaging Market?